Equities analysts predict that Procter & Gamble Co (NYSE:PG) will post earnings of $1.24 per share for the current quarter, according to Zacks. Six analysts have made estimates for Procter & Gamble’s earnings. The highest EPS estimate is $1.27 and the lowest is $1.18. Procter & Gamble reported earnings of $1.12 per share in the same quarter last year, which indicates a positive year over year growth rate of 10.7%. The business is expected to announce its next quarterly earnings report on Friday, October 18th.
On average, analysts expect that Procter & Gamble will report full year earnings of $4.84 per share for the current financial year, with EPS estimates ranging from $4.75 to $4.91. For the next fiscal year, analysts anticipate that the business will post earnings of $5.15 per share, with EPS estimates ranging from $5.00 to $5.30. Zacks Investment Research’s earnings per share calculations are an average based on a survey of sell-side research analysts that follow Procter & Gamble.
Procter & Gamble (NYSE:PG) last announced its quarterly earnings data on Tuesday, July 30th. The company reported $1.10 EPS for the quarter, topping the Zacks’ consensus estimate of $1.06 by $0.04. Procter & Gamble had a return on equity of 23.03% and a net margin of 5.76%. The firm had revenue of $17.09 billion for the quarter, compared to the consensus estimate of $16.86 billion. During the same quarter last year, the business posted $0.94 earnings per share. The firm’s revenue was up 3.6% compared to the same quarter last year.
Several research firms have weighed in on PG. UBS Group set a $122.00 price objective on shares of Procter & Gamble and gave the stock a “hold” rating in a research report on Wednesday, July 31st. SunTrust Banks upped their target price on shares of Procter & Gamble to $120.00 and gave the stock a “hold” rating in a research report on Wednesday, July 31st. Goldman Sachs Group upgraded shares of Procter & Gamble from a “neutral” rating to a “buy” rating and upped their target price for the stock from $114.00 to $125.00 in a research report on Thursday, June 27th. Royal Bank of Canada restated a “neutral” rating and issued a $89.00 price objective on shares of Procter & Gamble in a report on Tuesday, July 30th. Finally, Morgan Stanley set a $129.00 price objective on shares of Procter & Gamble and gave the company a “buy” rating in a report on Monday, August 12th. One equities research analyst has rated the stock with a sell rating, eleven have given a hold rating and twelve have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average price target of $108.15.
Procter & Gamble stock traded down $0.52 during trading on Friday, reaching $122.25. 194,453 shares of the company were exchanged, compared to its average volume of 6,182,078. Procter & Gamble has a 52-week low of $78.49 and a 52-week high of $123.43. The company has a market capitalization of $304.85 billion, a P/E ratio of 27.04, a PEG ratio of 3.48 and a beta of 0.42. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.75 and a quick ratio of 0.58. The stock’s 50 day simple moving average is $118.41 and its two-hundred day simple moving average is $109.40.
The company also recently announced a quarterly dividend, which was paid on Thursday, August 15th. Shareholders of record on Friday, July 19th were paid a $0.7459 dividend. This represents a $2.98 annualized dividend and a yield of 2.44%. The ex-dividend date of this dividend was Thursday, July 18th. Procter & Gamble’s payout ratio is presently 65.93%.
In related news, insider Mary Theresa Grabowski sold 5,200 shares of the stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $119.10, for a total transaction of $619,320.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Marylynn Fergusonmchugh sold 37,027 shares of the stock in a transaction on Monday, August 5th. The stock was sold at an average price of $116.00, for a total transaction of $4,295,132.00. Following the transaction, the chief executive officer now owns 112,703 shares of the company’s stock, valued at approximately $13,073,548. The disclosure for this sale can be found here. Insiders sold 448,674 shares of company stock valued at $53,197,461 in the last ninety days. Insiders own 1.75% of the company’s stock.
Institutional investors and hedge funds have recently made changes to their positions in the stock. Slow Capital Inc. increased its position in Procter & Gamble by 3.9% during the second quarter. Slow Capital Inc. now owns 2,317 shares of the company’s stock worth $254,000 after acquiring an additional 86 shares during the period. Stony Point Wealth Management Inc. boosted its position in Procter & Gamble by 0.7% during the 2nd quarter. Stony Point Wealth Management Inc. now owns 12,805 shares of the company’s stock worth $1,485,000 after buying an additional 91 shares during the period. Family Legacy Inc. boosted its position in Procter & Gamble by 0.6% during the 2nd quarter. Family Legacy Inc. now owns 16,162 shares of the company’s stock worth $1,772,000 after buying an additional 95 shares during the period. Merit Financial Group LLC boosted its position in Procter & Gamble by 1.6% during the 1st quarter. Merit Financial Group LLC now owns 6,082 shares of the company’s stock worth $632,000 after buying an additional 96 shares during the period. Finally, Earnest Partners LLC boosted its position in Procter & Gamble by 8.0% during the 2nd quarter. Earnest Partners LLC now owns 1,296 shares of the company’s stock worth $142,000 after buying an additional 96 shares during the period. Institutional investors and hedge funds own 65.83% of the company’s stock.
About Procter & Gamble
The Procter & Gamble Company provides branded consumer packaged goods to consumers in North America, Europe, the Asia Pacific, Greater China, Latin America, India, the Middle East, and Africa. The company operates in five segments: Beauty; Grooming; health Care; fabric & Home Care; and Baby, Feminine & Family Care.
Further Reading: Recession
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.